- Insulin-like growth factor-1 improves diabetic cardiomyopathy through antioxidative and anti-inflammatory processes along with modulation of Akt/GSK-3β signaling in rats
-
Wang CY, Li XD, Hao ZH, Xu D
- KMID: 2364265
- Korean J Physiol Pharmacol.
- 2016 Nov;20(6):613-619.
- doi: 10.4196/kjpp.2016.20.6.613
Diabetic cardiomyopathy (DCM), a serious complication of diabetes mellitus, is associated with changes in myocardial structure and function. This study sought to explore the ability of insulin-like growth factor-1 (IGF-1)... -
- CITED
-
- Close
- SHARE
-
- Close
